First Capital Advisors Group’s Biogen BIIB Stock Holding History

First Capital Advisors Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$530K	Buy	1,859 +308	+20%	+$91.7K	0.28%	72
2023 Q1	$431K	Sell	1,551 -10	-0.6%	-$2.77K	0.28%	80
2022 Q4	$432K	Sell	1,561 -82	-5%	-$23.2K	0.29%	84
2022 Q3	$439K	Sell	1,643 -490	-23%	-$104K	0.37%	77
2022 Q2	$435K	Buy	+2,133	New	+$436K	0.3%	82
2018 Q4	$308K	Buy	1,024 +46	+5%	+$14.7K	0.23%	91
2018 Q3	$346K	Sell	978 -156	-14%	-$53.7K	0.21%	98
2018 Q2	$329K	Sell	1,134 -252	-18%	-$70.8K	0.22%	98
2018 Q1	$380K	Buy	+1,386	New	+$430K	0.22%	87

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

First Capital Advisors Group's BIIB Position: Q2 2023 in Review

First Capital Advisors Group increased its Biogen (BIIB) stake by 20% in Q2 2023, buying an estimated $91.7K and bringing the position to 1,859 shares worth $530K. The position accounts for 0.28% of the portfolio, ranked #72.

First Capital Advisors Group first reported a position in BIIB in Q1 2018 and has held it in 9 quarters since. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

First Capital Advisors Group held 1,859 shares of Biogen worth $530K as of Q2 2023.
First Capital Advisors Group bought 308 Biogen shares in Q2 2023, an estimated $91.7K.
Biogen made up 0.28% of First Capital Advisors Group's portfolio in Q2 2023, its #72 holding.
First Capital Advisors Group first reported a position in Biogen in Q1 2018 and has held it in 9 quarters since.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.